Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Completed · Phase 3 · Has a placebo group
Conditions studied: Diabetes, Diabetes Mellitus, Type 2
In brief
This trial is conducted globally. The aim of the trial is to investigate the efficacy and safety of oral semaglutide versus placebo in subjects with Type 2 Diabetes Mellitus treated with insulin. All subjects should continue their pre-trial insulin therapy (basal, basal-bolus or premixed regimen including combinations of soluble insulins) throughout the trial. Subjects treated with metformin in addition to insulin treatment must continue their metformin treatment throughout the entire trial.
Key facts
- Study ID
- NCT03021187
- Run by
- Novo Nordisk A/S
- People needed
- 731
- Starts
- 2017-02-02
- Expected to finish
- 2018-08-22
- Last updated by the study team
- 2020-03-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novo Nordisk Investigational Site — London, Ontario, Canada
- Novo Nordisk Investigational Site — Toronto, Ontario, Canada
- Novo Nordisk Investigational Site — Waterloo, Ontario, Canada
- Novo Nordisk Investigational Site — Besançon, France
- Novo Nordisk Investigational Site — Bourgoin, France
- Novo Nordisk Investigational Site — Brest, France
- Novo Nordisk Investigational Site — La Roche-sur-Yon, France
- Novo Nordisk Investigational Site — La Rochelle, France
- Novo Nordisk Investigational Site — Le Coudray, France
- Novo Nordisk Investigational Site — Le Creusot, France
- Novo Nordisk Investigational Site — Narbonne, France
- Novo Nordisk Investigational Site — Paris, France
- Novo Nordisk Investigational Site — Saint-Herblain, France
- Novo Nordisk Investigational Site — Toulouse, France
- Novo Nordisk Investigational Site — Vénissieux, France
- Novo Nordisk Investigational Site — Athens, Greece
- Novo Nordisk Investigational Site — Athens, Greece
- Novo Nordisk Investigational Site — Ioannina, Greece
- Novo Nordisk Investigational Site — Larissa, Greece
- Novo Nordisk Investigational Site — Piraeus, Greece
- Novo Nordisk Investigational Site — Thessaloniki, Greece
- Novo Nordisk Investigational Site — Ahmedabad, Gujarat, India
- Novo Nordisk Investigational Site — Bangalore, Karnataka, India
- Novo Nordisk Investigational Site — Kozhikode, Kerala, India
- Novo Nordisk Investigational Site — Etobicoke, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.